VLKIM
NVO

Van Lanschot Kempen Investment Management’s Novo Nordisk NVO Stock Holding History

Van Lanschot Kempen Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,202
Closed -$42K – 176
2020
Q3 		$42K Hold
1,202
– – ﹤0.01% 148
2020
Q2 		$39K Sell
1,202
-3,972
-77% -$127K ﹤0.01% 154
2020
Q1 		$156K Buy
5,174
+1,148
+29% +$34.2K 0.01% 156
2019
Q4 		$117K Sell
4,026
-23,060
-85% -$639K 0.01% 170
2019
Q3 		$700K Buy
+27,086
New +$685K 0.06% 134

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

Van Lanschot Kempen Investment Management's NVO Position: Q4 2020 in Review

Van Lanschot Kempen Investment Management sold out of Novo Nordisk (NVO) in Q4 2020, closing a stake of 1,202 shares — an estimated $42K sold.

Van Lanschot Kempen Investment Management first reported a position in NVO in Q3 2019 and held it in 5 quarters. The position peaked at $700K in Q3 2019. 703 funds tracked by Wall St. Rank hold NVO as of Q4 2020.

  • Van Lanschot Kempen Investment Management reported no remaining Novo Nordisk position as of Q4 2020 after selling out during the quarter.
  • Van Lanschot Kempen Investment Management sold 1,202 Novo Nordisk shares in Q4 2020, an estimated $42K.
  • Van Lanschot Kempen Investment Management first reported a position in Novo Nordisk in Q3 2019 and held it in 5 quarters.
  • Van Lanschot Kempen Investment Management's Novo Nordisk position peaked at $700K in Q3 2019.
  • 703 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2020.

Based on Van Lanschot Kempen Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.